Cargando…
Evaluation of TorsinA as a Target for Parkinson Disease Therapy in Mouse Models
Parkinson disease (PD) is a common and disabling disorder. No current therapy can slow or reverse disease progression. An important aspect of research in this field is target validation, a systematic approach to evaluating the likelihood that modification of a certain molecule, mechanism or biologic...
Autores principales: | Li, Xinru, Lee, Jenny, Parsons, Dee, Janaurajs, Karen, Standaert, David G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503809/ https://www.ncbi.nlm.nih.gov/pubmed/23185535 http://dx.doi.org/10.1371/journal.pone.0050063 |
Ejemplares similares
-
TorsinA: a therapeutic target for ALS?
Publicado: (2014) -
TorsinA and the TorsinA-Interacting Protein Printor Have No Impact on Endoplasmic Reticulum Stress or Protein Trafficking in Yeast
por: Valastyan, Julie S., et al.
Publicado: (2011) -
TorsinA regulates the LINC to moving nuclei
por: Starr, Daniel A., et al.
Publicado: (2017) -
TorsinA participates in endoplasmic reticulum-associated degradation
por: Nery, Flávia C., et al.
Publicado: (2011) -
Resolving the TorsinA Oligomerization Conundrum: The Glycan Hypothesis
por: Fercher, Christian, et al.
Publicado: (2020)